PPA
LAB icon

Parametric Portfolio Associates’s Standard BioTools LAB Stock Holding History

Parametric Portfolio Associates’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$102K Buy
28,471
+1,886
+7% +$6.51K ﹤0.01% 3558
2021
Q4 		$104K Sell
26,585
-9,501
-26% -$44.5K ﹤0.01% 3545
2021
Q3 		$238K Buy
36,086
+1,925
+6% +$12.7K ﹤0.01% 3382
2021
Q2 		$210K Buy
34,161
+15,122
+79% +$80.8K ﹤0.01% 3392
2021
Q1 		$86K Sell
19,039
-1,220
-6% -$6.7K ﹤0.01% 3983
2020
Q4 		$122K Sell
20,259
-2,312
-10% -$15.2K ﹤0.01% 3865
2020
Q3 		$168K Buy
22,571
+3,309
+17% +$22.8K ﹤0.01% 3709
2020
Q2 		$77K Sell
19,262
-7,222
-27% -$25.2K ﹤0.01% 3821
2020
Q1 		$67K Sell
26,484
-3,752
-12% -$12.3K ﹤0.01% 3794
2019
Q4 		$105K Sell
30,236
-13,831
-31% -$48.7K ﹤0.01% 3856
2019
Q3 		$204K Sell
44,067
-82,954
-65% -$653K ﹤0.01% 3702
2019
Q2 		$1.56M Sell
127,021
-16,257
-11% -$207K ﹤0.01% 2817
2019
Q1 		$1.9M Buy
143,278
+115,808
+422% +$1.22M ﹤0.01% 2693
2018
Q4 		$237K Sell
27,470
-5,355
-16% -$41.7K ﹤0.01% 3596
2018
Q3 		$246K Sell
32,825
-7,399
-18% -$52.6K ﹤0.01% 3682
2018
Q2 		$240K Buy
40,224
+2,266
+6% +$12.9K ﹤0.01% 3639
2018
Q1 		$222K Buy
37,958
+689
+2% +$4.52K ﹤0.01% 3724
2017
Q4 		$220K Sell
37,269
-705
-2% -$3.86K ﹤0.01% 3718
2017
Q3 		$191K Buy
37,974
+15,517
+69% +$65.2K ﹤0.01% 3869
2017
Q2 		$91K Buy
+22,457
New +$106K ﹤0.01% 3927
2017
Q1 		– Sell
-10,391
Closed -$76K – 3799
2016
Q4 		$76K Sell
10,391
-11,123
-52% -$69.8K ﹤0.01% 3723
2016
Q3 		$172K Buy
21,514
+444
+2% +$4.08K ﹤0.01% 3611
2016
Q2 		$190K Buy
21,070
+9,939
+89% +$93.4K ﹤0.01% 3623
2016
Q1 		$90K Buy
+11,131
New +$80.3K ﹤0.01% 3878
2015
Q3 		– Sell
-8,287
Closed -$201K – 3306
2015
Q2 		$201K Sell
8,287
-5,290
-39% -$167K ﹤0.01% 3768
2015
Q1 		$572K Buy
13,577
+886
+7% +$35K ﹤0.01% 3186
2014
Q4 		$428K Buy
+12,691
New +$359K ﹤0.01% 3353

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parametric Portfolio Associates's LAB Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Standard BioTools (LAB) stake by 7.1% in Q1 2022, buying an estimated $6.51K and bringing the position to 28,471 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #3558.

Parametric Portfolio Associates first reported a position in LAB in Q4 2014 and has held it in 27 quarters since. The position peaked at $1.9M in Q1 2019. 109 funds tracked by Wall St. Rank hold LAB as of Q1 2022.

  • Parametric Portfolio Associates held 28,471 shares of Standard BioTools worth $102K as of Q1 2022.
  • Parametric Portfolio Associates bought 1,886 Standard BioTools shares in Q1 2022, an estimated $6.51K.
  • Standard BioTools made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3558 holding.
  • Parametric Portfolio Associates first reported a position in Standard BioTools in Q4 2014 and has held it in 27 quarters since.
  • Parametric Portfolio Associates's Standard BioTools position peaked at $1.9M in Q1 2019.
  • 109 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.